View in EDS HTML Full Text PDF Full Text

Unveiling HJURP as a Biomarker of Poor Prognosis and Immunotherapy Resistance in Lung Adenocarcinoma: A Multicenter Study.

Saved in:
Bibliographic Details
Title: Unveiling HJURP as a Biomarker of Poor Prognosis and Immunotherapy Resistance in Lung Adenocarcinoma: A Multicenter Study.
Authors: Tan, Qinglin1 (AUTHOR), Kong, Peiliang2 (AUTHOR), Chen, Guobiao3 (AUTHOR), Chen, Chen1 (AUTHOR), Mo, Huiting1 (AUTHOR), Huang, Yuancheng1 (AUTHOR), Zhang, Manman1 (AUTHOR), Cai, Yanmin1 (AUTHOR), Zhang, Hanbin4 (AUTHOR), Lu, Jianming5 (AUTHOR), Wu, Yifen1 (AUTHOR) 31200195@smu.edu.cn
Source: Clinical Medicine Insights: Oncology. 10/27/2025, Vol. 19, p1-15. 15p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:11795549
DOI:10.1177/11795549251388872